Skip to main content

Table 2 Association between TOP2A expression and biochemical recurrence-free survival

From: Prognostication of prostate cancer based on TOP2A protein and gene assessment: TOP2A in prostate cancer

TOP2A intensity

Median (months)

p*

1+ (weak)

60.230

0.001

2+ (moderate)

29.375

3+ (strong)

16.743

 
  1. * Statistically significant p values inferior to 0.05.
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us